Theriault R - Search Results

1

Phase II study of deoxyspergualin in metastatic breast cancer.

Dhingra K, Valero V, Gutierrez L, Theriault R, Booser D, Holmes F, Buzdar A, Fraschini G, Hortobagyi G. Dhingra K, et al. Among authors: theriault r. Invest New Drugs. 1994;12(3):235-41. doi: 10.1007/BF00873965. Invest New Drugs. 1994. PMID: 7896543 Clinical Trial.

2

A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer.

Wallerstein R Jr, Spitzer G, Dunphy F, Huan S, Hortobagyi G, Yau J, Buzdar A, Holmes F, Theriault R, Ewer M, et al. Wallerstein R Jr, et al. Among authors: theriault r. J Clin Oncol. 1990 Nov;8(11):1782-8. doi: 10.1200/JCO.1990.8.11.1782. J Clin Oncol. 1990. PMID: 2121909

3

Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.

Dhingra K, Frye D, Newman RA, Walters R, Theriault R, Fraschini G, Smith T, Buzdar A, Hortobagyi GN. Dhingra K, et al. Among authors: theriault r. Clin Cancer Res. 1995 Jul;1(7):691-7. Clin Cancer Res. 1995. PMID: 9816034 Clinical Trial.

4

Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.

Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK, Hortobagyi GN. Holmes FA, et al. Among authors: theriault rl. J Natl Cancer Inst. 1991 Dec 18;83(24):1797-805. doi: 10.1093/jnci/83.24.1797-a. J Natl Cancer Inst. 1991. PMID: 1683908 Clinical Trial.

5

Phase I-II study of high-dose etoposide in patients with refractory breast cancer.

Fraschini G, Holmes FA, Esparza L, Theriault RL, Buzdar AU, Hortobagyi GN. Fraschini G, et al. Among authors: theriault rl. Invest New Drugs. 1991 Nov;9(4):365-7. doi: 10.1007/BF00183583. Invest New Drugs. 1991. PMID: 1804815 Clinical Trial. No abstract available.

6

Pirarubicin in combination chemotherapy for metastatic breast cancer.

Hortobagyi GN, Theriault RL, Frye D, Walters RS, Fraschini G, Tashima CK, Ro JS, Salewski E, Buzdar AU. Hortobagyi GN, et al. Among authors: theriault rl. Am J Clin Oncol. 1990;13 Suppl 1:S54-6. doi: 10.1097/00000421-199012001-00012. Am J Clin Oncol. 1990. PMID: 2291460

7

Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer.

Theriault RL, Hortobagyi GN, Kau SW, Holmes FA, Hug V, Fraschini G, Jabboury K, Buzdar AU. Theriault RL, et al. Cancer. 1988 Nov 15;62(10):2105-10. doi: 10.1002/1097-0142(19881115)62:10<2105::aid-cncr2820621006>3.0.co;2-n. Cancer. 1988. PMID: 3179923

8

Phase II study of recombinant alpha-interferon and recombinant interleukin-2 metastatic breast cancer.

Walters RS, Theriault RL, Holmes FA, Esparza L, Hortobagyi GN. Walters RS, et al. Among authors: theriault rl. J Immunother Emphasis Tumor Immunol. 1994 Nov;16(4):303-5. doi: 10.1097/00002371-199411000-00008. J Immunother Emphasis Tumor Immunol. 1994. PMID: 7881639 Clinical Trial.

9

The M. D. Anderson Cancer Center experience with Taxol in metastatic breast cancer.

Holmes FA, Valero V, Walters RS, Theriault RL, Booser DJ, Fraschini G, Buzdar AU, Frye D, Gibbs HR, Hortobagyi GN. Holmes FA, et al. Among authors: theriault rl. J Natl Cancer Inst Monogr. 1993;(15):161-9. J Natl Cancer Inst Monogr. 1993. PMID: 7912522 Clinical Trial.

10

Use of Taxol (paclitaxel) in breast cancer.

Hortobagyi GN, Holmes FA, Theriault RL, Buzdar AU. Hortobagyi GN, et al. Among authors: theriault rl. Oncology. 1994 Oct;51 Suppl 1:29-32. doi: 10.1159/000227413. Oncology. 1994. PMID: 7970507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

311 results

Search Page

Filters